- Why cost-effectiveness thresholds should not decline during a pandemic.
- IVI on value assessment.
- Identifying your rare disease.
- Binding arbitration and out-of-network billing.
- COVID surge over Labor Day?
from Healthcare Economist https://ift.tt/333wPT8
via IFTTT
No comments:
Post a Comment